Incidence of Genital Warts in Adolescents and Young Adults in an Integrated Health Care Delivery System in the United States Before Human Papillomavirus Vaccine Recommendations

2013 ◽  
Vol 40 (7) ◽  
pp. 534-538 ◽  
Author(s):  
Deepa R. Camenga ◽  
Eileen F. Dunne ◽  
Mayur M. Desai ◽  
Julianne Gee ◽  
Lauri E. Markowitz ◽  
...  
Keyword(s):  
United States ◽  
Health Care ◽  
Human Papillomavirus ◽  
Care Delivery ◽  
The United States ◽  
Genital Warts ◽  
Health Care Delivery System ◽  
Human Papillomavirus Vaccine ◽  
Vaccine Recommendations ◽  
Papillomavirus Vaccine

scholarly journals Human papillomavirus vaccine initiation among 9–13-year-olds in the United States

2015 ◽  
Vol 2 ◽  
pp. 892-898 ◽  
Author(s):  
Kelly L. Donahue ◽  
Kristin S. Hendrix ◽  
Lynne A. Sturm ◽  
Gregory D. Zimet
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
The United States ◽  
Human Papillomavirus Vaccine ◽  
Vaccine Initiation ◽  
Papillomavirus Vaccine

scholarly journals The Implementation and Evaluation of the United States Affordable Care Act

2019 ◽  
Vol 12 (1) ◽  
pp. 17-38
Author(s):  
David Schultz
Keyword(s):  
United States ◽  
Health Care ◽  
Affordable Care Act ◽  
Access To Health Care ◽  
Care Delivery ◽  
The United States ◽  
Health Care Delivery System ◽  
Health Care Outcomes ◽  
The Us ◽  
American Health Care

In 2010 the United States Congress adopted the Patient Protection and Affordable Care Act (“ACA”), more commonly referred to as Obamacare. The ACA was proposed by President Barack Obama while running for president and it was passed with a near straight party-line vote of Democrats in the US House and Senate in 2010. The ACA was meant to address several problems with the American health care delivery system, including cost, access and outcomes. This article describes the major features of the ACA including the context of the US health care system, evaluates the ACA’s implementation history and assesses its fate and future reforms throughout the presidency of Donald Trump. The overall conclusion based on its implementation is that while the ACA made significant reforms in terms of access to health care, it is not clear that it addressed affordability or began to improve health care outcomes in the US.

scholarly journals 962. Trends in Cervical Pre-cancers by Race and Ethnicity During the Human Papillomavirus Vaccine Era, HPV Vaccine Impact Monitoring Project (HPV-IMPACT), United States, 2008–2016

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S29-S29
Author(s):  
Julia Gargano ◽  
Rayleen Lewis ◽  
Hillary Hunt ◽  
Nancy McClung ◽  
Nancy M Bennett ◽  
...  
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
Hpv Vaccine ◽  
The United States ◽  
Adenocarcinoma In Situ ◽  
Human Papillomavirus Vaccine ◽  
Impact Monitoring ◽  
Vaccine Impact ◽  
Race Ethnicity ◽  
Papillomavirus Vaccine

Abstract Background Since human papillomavirus (HPV) vaccine introduction in the United States in 2006, cervical pre-cancer incidence has declined in young women, but pre-cancer trends have not been reported by race/ethnicity. We evaluated trends in cervical pre-cancers from 2008 to 2016 in non-Hispanic (NH) white, NH black, NH Asian, and Hispanic women identified through active population-based surveillance in the 5-site Human Papillomavirus Vaccine Impact Monitoring Project (HPV-IMPACT). Methods We analyzed data on cervical intraepithelial neoplasia (CIN) grades 2–3 and adenocarcinoma in situ (CIN2+) cases aged 20–39 years. Annual CIN2+ rates per 100,000 women were calculated stratified by race/ethnicity in 5-year age groups, using multiple imputation to account for 10% missing race/ethnicity data. Rates were also calculated using estimated numbers screened for cervical cancer to control for known declines in screening. Trends, evaluated using JoinPoint software, are presented as average annual percentage changes (AAPC) with 95% confidence intervals (CI). Results A total of 18,222 CIN2+ cases (62% NH white, 16% NH black, 16% Hispanic, 6% Asian) were reported from 2008 to 2016. CIN2+ rates among 20–24 year-olds declined significantly in all groups: NH white, AAPC: −14.2 (95% CI: −16.3, −12.1); NH black, AAPC: −15.5 (−19.5, −11.4); Asian, AAPC: −14.8 (−20.5, −8.8); Hispanic, AAPC: −14.3 (−17.9, −10.5). In 25–29 year olds, a significant decline was observed for NH whites only (AAPC: −2.4, [−4.0, −0.8]). No declines were seen in 30–34 or 35–39 year olds. Among screened 20–24 year-olds, significant but smaller declines were observed (AAPC: −9.8 to −8.4); no declines were observed in screened 25–29 year olds or older groups. Conclusion In this evaluation of CIN2+ trends by race/ethnicity during the HPV vaccine era, the significant declines in 20–24 year olds across all groups, including among screened women, is consistent with equitable vaccine impact on CIN2+. Disclosures All Authors: No reported Disclosures.

scholarly journals Early Policy Responses to the Human Papillomavirus Vaccine in the United States, 2006–2010

2014 ◽  
Vol 55 (5) ◽  
pp. 659-664 ◽  
Author(s):  
Miriam J. Laugesen ◽  
Ritesh Mistry ◽  
Kelley A. Carameli ◽  
Kurt M. Ribisl ◽  
Jack Needleman ◽  
...  
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
The United States ◽  
Human Papillomavirus Vaccine ◽  
Policy Responses ◽  
Papillomavirus Vaccine

scholarly journals Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States

Cancer ◽  
2015 ◽  
Vol 121 (16) ◽  
pp. 2775-2781 ◽  
Author(s):  
Susan Hariri ◽  
Michelle L. Johnson ◽  
Nancy M. Bennett ◽  
Heidi M. Bauer ◽  
Ina U. Park ◽  
...  
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
The United States ◽  
Population Based ◽  
High Grade ◽  
Human Papillomavirus Vaccine ◽  
Cervical Lesions ◽  
Papillomavirus Vaccine ◽  
Early Human
Sign in / Sign up

Export Citation Format

Share Document